Oncology
PG7 Postgraduate Course
New guidelines for the classification and staging of lung cancer
Clinical
Registration for this session is additional to the congress registration fee and is €140 on site, €125 standard or €95 for early bird registration.
Aims : Access educational materials here
To present and disseminate the new guidelines concerning the pathological classification of lung cancer and the 9th American Joint Committee on Cancer staging guidelines; to analyse the molecular-pathological correlations in lung cancer; and to describe the staging techniques needed to implement the new guidelines.
Target audience :
Clinician, Epidemiologist, General practitioner, Junior member, Oncologist, Pathologist, Pulmonologist, Resident, Respiratory physician, Scientist, Student, Thoracic surgeon, Trainee
09:30
The new World Health Organisation classification of lung cancer
P. Schnabel(Homburg (Saar), Germany)
COI
-
Description
1
59
10:15
Molecular-pathological correlations in lung cancer
E. Brambilla(Grenoble, France)
COI
-
Description
2
60
11:30
TNM descriptor and classification changes in the 8th edition
P. Goldstraw(London, United Kingdom)
COI
-
Description
4
62
12:15
Staging techniques needed for implementing the new staging recommendations
T. Blum(Berlin, Germany)
COI
-
Description
5
63
. . .